Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ET-600 by Eton Pharmaceuticals for Diabetes Insipidus: Likelihood of Approval
ET-600 is under clinical development by Eton Pharmaceuticals and currently in Phase I for Diabetes Insipidus. According to GlobalData, Phase...